On-X Life Technologies to launch its On-X Plus 1.5 Aortic Heart Valve

On-X Life Technologies to launch its On-X® Plus 1.5™ Aortic Heart Valve at Annual Meeting of the Society for Cardiothoracic Surgery (SCS) in Great Britain & Ireland “The On-X® Plus 1.5™ Aortic Heart Valve allows clinicians to maintain patients on a lower dose of blood thinner, which has been shown to result in greater than […]

“I wanted the best….”

When I was told that I needed surgery to repair aneurysm on my Acending Aorta, I was extremely nervous to say the least. I then found that I had a bicuspid valve and that too needed to be replace. I was in the military so I really was at the mercy of what ever the […]


After 14 years of watchful waiting, four years after a mitral balloon valvuloplasty, I could no longer hit my golf ball and walk to it without becoming breathless. A stress echo showed it was time to replace my diseased and leaking mitral valve.  There was no doubt in my mind that I would have an […]

Clinical Update Forty-Six: Recently Approved in Europe

Recently Approved in Europe — Lower Anticoagulation Maintenance of Aortic Heart Valve Recipients!1 Introducing the On-X® Plus 1.5™ Aortic Heart Valve: Significantly reduced bleeding for On-X aortic heart valve patients does not increase the stroke rate.2   European aortic valve patients can now take less warfarin for lowered bleeding rates The On-X valve is the […]

Clinical Update Forty-Five: Tissue Valve Failure

Factors leading to premature tissue valve failure Accelerated failure of biological valve replacements due to diabetes, atherosclerosis, metabolic syndrome, hypercholesterolemia and patient-prosthesis mismatch puts patients at risk.1-5   Recently published studies describe a variety of conditions common in patients with heart valve disease that can cause early tissue valve failure. Diabetes is a 3X higher […]

On-X Life Technologies reports CE mark approval

On-X Life Technologies reports CE mark approval to sell its mechanical aortic heart valve with an expanded labeling claim: a reduction in the required use of blood thinners “This approval allows European clinicians to maintain patients on a lower dose of anticoagulant, which has been shown in a multicenter clinical trial (PROACT: Prospective On-X Anticoagulation […]

Interim Results From the PROACT Randomized FDA IDE Trial

Reduced Anticoagulation After Mechanical Aortic Valve Replacement Narrated slide presentation from The American Association for Thoracic Surgery Annual Meeting 2013, Minneapolis, Minnesota, USA, on May 6, 2013

Aortic Aneurysm Success Story

“When my cardiologist indicated it was time for me to surgically address my ascending aortic aneurysm and degrading aortic valve, I undertook some research into what would be my best choice. I did not want to face the prospect of another open heart procedure when in my 80s, as would probably be required if I […]

“My On-X Valves have been great!”

“The On-X valves have been great. I have two of your valves–aortic and mitral. They are not too loud and do not keep me or my wife awake at night. I had surgery to replace my aortic and mitral valves in November of 2006. I researched heart valves on the internet and talked with patients […]

“The On-X Valve was just what I had surmised”

“I opted for an aortic valve repair 8.5 years ago because I was hoping that a new improved mechanical valve would come along before I needed my next operation. The repair worked for a little over 8 years and fortunately, the on-x valve was just what I had surmised and hoped would come to market. […]

Onxlti Responsive Menu